[Substantation of usefulness of the combined sorption therapy in women in childbirth who have high risk of septic complications].
Features of immune and cytokine status of women in childbirth who had high risk of septic complications and were under combined enteral and application sorption therapy with SILLARD-II have been studied. A new method of prophylaxis of septic complications in women who underwent Cesarean section and had a high risk of septic complications have been developed and introduced into practice. The author has showed that this proposed method is effective based on immune and cytokine status of women in childbirth.
Khodakivs'kyĭ
S B
SB
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D002585:Cesarean Section; D003131:Combined Modality Therapy; D016061:Enterosorption; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D015847:Interleukin-4 / Q000097:blood; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D011183:Postoperative Complications; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D018805:Sepsis / Q000097:blood / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D000900:Anti-Bacterial Agents; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4